NCT00637026View on ClinicalTrials.gov

Ph II Early BC Pre-Surgical Biologic Study

PHASE2CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

February 28, 2005

Conditions
Breast Cancer
Interventions
DRUG

Gefitinib

Iressa

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Cancer International Research Group (CIRG)

OTHER

lead

AstraZeneca

INDUSTRY

NCT00637026 - Ph II Early BC Pre-Surgical Biologic Study | Biotech Hunter | Biotech Hunter